Related Experiment Videos
Acute myeloblastic leukemia as a second malignancy in a patient with hereditary retinoblastoma
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Insulin-dependent formation of a complex containing an 85-kDa subunit of phosphatidylinositol 3-kinase and tyrosine-phosphorylated insulin receptor substrate 1.
The Journal of biological chemistry·1992
[Activity of Enterococcus faecalis (FK-23) preparation as a biological response modifier].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·1992
Affinity cross-linked delta-opioid receptor in NG108-15 cells is low molecular weight (25 kDa) and coupled to GTP-binding proteins.
European journal of pharmacology·1992
Carinal transplantation.
Thorax·1992
Efficient selection of mu m-mutants from mu m-expressing myeloma cells by treatment with ricin A-conjugated anti-mu antibody.
Somatic cell and molecular genetics·1992
Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
LymphGen-Sig: Integrating Genetic and Transcriptional States to Predict Therapeutic Response in Diffuse Large B-Cell Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Risk-Adapted Optimization of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2-Positive Early-Stage Breast Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Purple Blossoms.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026